Navigation Links
Bay Area Women Sought for Egg Freezing Study
Date:9/28/2007

Reproductive Science Center of the San Francisco Bay research seeks couples

with male factor infertility

SAN RAMON, Calif., Sept. 28 /PRNewswire/ -- Reproductive Science Center of the San Francisco Bay Area, in cooperation with ViaCell, Inc., has been awarded a research grant to evaluate the safety and effectiveness of ViaCyte, an investigational product intended to broaden reproductive options for women through freezing and thawing of human eggs (oocytes). RSC's IVF and Medical Director Dr. Louis Weckstein is the principal clinical investigator.

The study seeks couples with male factor infertility who want to achieve pregnancy. Female participants must be healthy, between the ages of 21 and 35, and must not have had more than one previous miscarriage or more than one failed in vitro fertilization (IVF) attempt. The couple must be willing to undergo egg retrieval with an egg freeze and thaw, after which they will undergo intracytoplasmic sperm injection (ICSI) and embryo transfer in order to achieve pregnancy. Women enrolling in this study will have their procedures performed at RSC and should anticipate a time commitment of approximately 12-months (three to four months for a standard IVF cycle, cryopreservation and thaw of oocytes, embryo transfer, and up to nine months for the resulting pregnancy follow-up). There is no cost to any enrolled patients for their treatment in the course of this study.

Human oocyte cryopreservation or egg freezing has been investigated since the 1980's and has been used experimentally in certain IVF populations, in women who are undergoing cancer treatments who are at risk of losing their fertility, and in women choosing to preserve their fertility. There is currently no FDA-cleared product offered for oocyte cryopreservation. For more information regarding the study, please visit http://www.rscbayarea.com or call 925.973.5012.

About Reproductive Science Center

Established in 1983, the Reproductive Science Center of the San Francisco Bay Area was one of the earliest IVF facilities in the United States, begun just two years after the nation's first successful IVF treatment. RSC was among the first in the United States to report a successful pregnancy from an egg donated from one woman to another for gestation and delivery, and was also responsible for the nation's second successful transfer of a previously frozen embryo into a mother's uterus. Today, RSC boasts a staff of six infertility physicians with a collective 85 years' experience with offices in San Ramon, Orinda, San Jose, Fremont, Modesto, Brentwood, and Monterey. The Reproductive Science Center is a member of IntegraMed, a national network of 30 fertility centers in 95 locations across the United States. Nearly one of every four IVF procedures in the United States is performed in an IntegraMed practice. For more information, visit http://www.rscbayarea.com. Available Topic Expert(s): For information on the listed expert(s), click appropriate link. Dr. Louis Weckstein http://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=58599


'/>"/>
SOURCE Reproductive Science Center
Copyright©2007 PR Newswire.
All rights reserved

Related medicine technology :

1. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
2. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. New Analysis of WHI Data Shows Reduced Levels of Coronary Artery Calcification, a Predictor of Cardiovascular Events, in Women aged 50-59 taking Estrogen Therapy
5. Allos Therapeutics Reports Results for Phase 3 Enrich Study of Efaproxyn in Women With Brain Metastases Originating From Breast Cancer
6. First single breast cancer study to show significant survival benefit for women switching from tamoxifen to Arimidex
7. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
8. Women Well-Informed About Breast Cancer, Yet Lacking Knowledge About Current Treatments, New Survey Finds
9. Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides Sustained Immune Response in 100 Percent of Women up to 55 Years of Age
10. Antidepressant Use May Boost Fracture Risk, From Harvard Womens Health Watch
11. Limiting Eligibility for Medical Studies Can Omit Women, African-Americans, Stanford Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb.8, 2016 Aesthetic Devices - ... Medical Devices sector report, "Aesthetic Devices - Medical Devices ... currently in pipeline stage. This report ... and primary research by GlobalData,s team of industry experts. ... removed or altered based on the availability and relevance ...
(Date:2/8/2016)... SAN DIEGO , Feb. 8, 2016  Neurocrine ... the Company will report its fourth quarter and year-end ...  February 11, 2016.  Neurocrine will then host a live ... and provide a Company update Thursday afternoon, February 11, ... Time). http://www.neurocrine.com . --> http://www.neurocrine.com ...
(Date:2/8/2016)... N.J. , Feb. 8, 2016   GS1 ... healthcare professionals to guide them through GS1 Standards implementation ... Drug Administration (FDA) Unique Device Identification (UDI) rule. ... GS1 US; Beth Gibson , senior director industry ... , industry development director, GS1 US --> ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... February 08, 2016 , ... ... today that nominations will be accepted February 8, 2016 through May 8, ... Awards include the Information Security Executive® of the Year, which recognizes executives ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... 50% lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with ... time to make a change in public health,” states Carole Baggerly, Director of ...
(Date:2/8/2016)... ... February 08, 2016 , ... The schedule is now ... country. The AutismOne 2016 Conference, which is being held May 25-29 at the Loews ... elsewhere about helpful interventions and causes of chronic illness in children. , Very recent ...
(Date:2/7/2016)... ... February 07, 2016 , ... ... has added Kybella® to his medical and surgical expertise. Technically known as deoxycholic ... injectable medication used as a non-surgical alternative for reduction of fat below the ...
(Date:2/6/2016)... Pekin, IL (PRWEB) , ... February 06, 2016 ... ... the recovery phases of eating disorder treatment helps to reduce the frequency and ... “Tasks of the Recovery Phase: Re-Establishing Healthy Identity and Purpose,” will explore the ...
Breaking Medicine News(10 mins):